Company intelligence / Profile preview

Velpharm

Ownership: Private
Development stage: Other

Overview

Velpharm is a fully integrated Russian pharmaceutical manufacturer focusing on modern, affordable, and high-quality generic medicines across multiple therapeutic areas. The company markets over 35 products, has about 120 undergoing registration, and 50 in development. The majority of Velpharm's portfolio consists of vital and essential medicines, with a strong emphasis on increasing drug bioavailability through advanced formulation and manufacturing technology.

Modalities: Small molecule
Industry: Biotech

Drug pipeline

2 assets

Acyclovir Velpharm

Unknown

1 more asset in the full pipeline.

Beyond the preview

Go deeper on Velpharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Velpharm.